Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression

By HospiMedica International staff writers
Posted on 29 Sep 2025

Medical implants such as stents, prosthetics, and drug-release systems often rely on batteries that take up space, wear out, and eventually require replacement surgery. More...

These limitations increase risks for patients and create barriers to the development of long-lasting, self-sustaining implant technologies. Now, a novel innovation aims to overcome this challenge by harvesting energy from both flowing fluids and wireless signals, paving the way for longer-lasting implants that may never require a battery replacement.

Researchers at RMIT University (Melbourne, Australia) have developed an experimental 3D-printed device made from diamond–titanium composite. By embedding semiconductive diamond particles into titanium, the research team transformed a traditionally passive implant material into an active, multifunctional system. The innovation allows the implant to generate energy from liquid flow, receive wireless power through tissue, and sense changes in flow without requiring onboard electronics.

The device was tested in the lab using saline solutions instead of blood, demonstrating that fluid moving across its surface could produce a small but steady electrical signal. This effect is significant because most implant materials are either insulating or conducting, while this hybrid material combines both properties. The research, published in Advanced Functional Materials, demonstrates how the generated signal, when paired with wireless charging, could power low-energy medical devices.

The research team also showed that the composite can be 3D printed into complex, patient-tailored structures. This flexibility enables implants that are not only lightweight and durable but also electrically active, combining mechanical function with sensing or energy-scavenging capabilities. Such adaptability is particularly valuable for personalized implants that can both support the body and provide feedback on health conditions.

Going forward, the technology could enable medical implants that never need a battery replacement and can continuously monitor patient health. This would enable safer implantable devices that could warn of disease progression before it becomes dangerous. The researchers are now seeking partners across biomedical and other sectors to advance testing and explore real-world applications.

“Our device can remotely detect changes in liquid flow in lab tests without the need for any active electronics in the implantable portion, which offers potential for future implants that could warn of progression of disease before it becomes dangerous,” said senior lead researcher Dr. Arman Ahnood, from RMIT’s School of Engineering

Related Links:
RMIT University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.